老年直肠癌术后辅助化疗相关病理特征及预后多因素分析
Postoperative adjuvant chemotherapy related pathological characteristics of elderly rectal cancer and multivariate analysis of prognosis

DOI: 10.6040/j.issn.1671-7554.0.2015.288

Keywords: 直肠肿瘤,辅助化疗,预后,病理特征,
Rectal noeplasm,Adjuvant chemotherapy,Prognosis,Pathological features

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	陈钰锋, 曾杨, 何晓生, 等. 影响Ⅱ期结直肠癌患者预后的临床病理因素分析[J]. 中华消化外科杂志, 2011, 10(6): 430-435. CHEN Yufeng, ZENG Yang, HE Xiaosheng, et al. Analysis of clinical pathological factors of prognosis of colorectal carcinoma[J]. Chinese Journal of Digestive Surgery, 2011, 10(6): 430-435.
[2]	Soumarova R, Boday A, Krhutova V, et al. Prognostic and predictive molecular biological markers in prostate cancer- significance of expression of genes PCA3 and TMPRSS2[J]. Neoplasma, 2015, 62(1): 114-118.
[3]	姜勇, 万远廉, 刘玉村, 等. 局部复发直肠癌187例手术疗效及预后因素分析[J]. 中华胃肠外科杂志, 2011, 14(8): 582-585. JIANG Yong, WAN Yuanlian, LIU Yucun, et al. Operation curative effect of prognostic factors in 187 cases of local recurrence of rectal cancer[J]. Chinese Journal of Gastrointestinal Surgery, 2011, 14(8): 582-585.
[4]	黄景山.老年直肠癌患者188例预后因素分析[J].中国老年学杂志, 2011, 31(17): 3260-3262. HUANG Jingshan. Prognostic factors in 188 cases of elderly patients with rectal cancer[J]. Chinese Journal of Geriatrics, 2011, 31(17): 3260-3262.
[5]	Schrag D, Weiser MR, Goodman KA, et al. Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial[J]. J Clin Oncol, 2014, 32(6): 513-518.
[6]	Kim MB, Hong TS, Wo JY. Treatment of stage Ⅱ-Ⅲ rectal cancer patients[J]. Curr Oncol Rep, 2014, 16(1): 362. doi: 10.1007/s11912-013-0362-0.
[7]	李清国, 赵广法, 王道荣, 等. 结直肠癌肝转移根治性切除预后因素分析[J]. 中华普通外科杂志, 2013, 28(9): 665-668. LI Qingguo, ZHAO Guangfa, WANG Daorong, et al. The prognostic factors analysis of liver metastases of colorectal cancer radical resection[J]. Chinese Journal of General Surgery, 2013, 28(9): 665-668.
[8]	梁峰, 张宏艳, 郝晓鹏, 等. 综合疗法治疗中晚期直肠癌26例[J]. 肿瘤研究与临床, 2012, 24(1): 54-55. LIANG Feng, ZHANG Hongyan, HAO Xiaopeng, et al. Comprehensive therapy in the treatment of 26 cases of advanced rectal cancer[J]. Cancer Research and Clinical, 2012, 24(1): 54-55.
[9]	Maggiori L, Bretagnol F, Aslam MI, et al. Does pathologic response of rectal cancer influence postoperative morbidity after neoadjuvant radiochemotherapy and total mesorectal excision[J]. Surgery, 2014, 155(3): 468-475.
[10]	郑成军,赵雪云,王健, 等. 264例直肠癌预后的影响因素分析[J]. 重庆医学, 2014, 43(1): 122-124. ZHENG Chengjun, ZHAO Xueyun, WANG Jian, et al. Influence factors of prognosis of 264 cases of patients with rectal cancer[J]. Chongqing Medicine, 2014, 43(1): 122-124.
[11]	肖毅, 陆君阳, 仲光熙, 等. 直肠癌新辅助强化治疗后肿瘤降期状况与生存预后[J]. 中华胃肠外科杂志, 2014(6): 547-550. XIAO Yi, LU Junyang, ZHONG Guangxi, et al. Down staging and the prognosis after neoadjuvant therapy of rectal cancer[J]. Chinese Journal of Gastrointestinal Surgery, 2014(6): 547-550.
[12]	Calvo FA, Morillo V, Santos M, et al. Interval between neoadjuvant treatment and definitive surgery in locally advanced rectal cancer: impact on response and oncologic outcome[J]. J Cancer Res Clin Oncol, 2014, 140(10): 1651-1660.
[13]	Kim H, Chie EK, Ahn YC, et al. Impact on loco-regional control of radiochemotherapeutic sequence and time to initiation of adjuvant treatment in stage Ⅱ/Ⅲ rectal cancer patients treated with postoperative concurrent radiochemotherapy[J]. Cancer Res Treat, 2014, 46(2): 148-157.
[14]	朱雄文, 吴崇山, 袁世超, 等. 淋巴结转移度与Ⅲ期直肠癌患者预后的关系[J]. 中华肿瘤杂志, 2012, 34(7): 506-509. ZHU Xiongwen, WU Chongshan, YUAN Shichao, et al. The relationship between the prognosis of patients with Ⅲ stage of rectal cancer and lymph node metastasis[J]. Chinese Journal of Oncology, 2012, 34(7):506-509.
[15]	Habr-Gama A, S？o Juli？o GP, Perez RO. Pitfalls of transanal endoscopic microsurgery for rectal cancer following neoadjuvant chemoradiation therapy[J]. Minim Invasive Ther Allied Technol, 2014, 23(2): 63-69.
[16]	Madbouly KM, Hussein AM, Abdelzaher E. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer[J]. Am J Surg, 2014, 208(3): 332-341.
[17]	蔡卫梅, 李伟伟. 自体CIK细胞联合同步放化疗治疗老年术后直肠癌的临床研究[J]. 现代预防医学, 2013, 40(8): 1564-1567. CAI Weimei, LI Weiwei. The autologous CIK cells combined with concurrent chemoradiotherapy in treatment of postoperative elderly patients with rectal cancer[J]. Modern Preventive Medicine, 2013, 40(8): 1564-1567.
[18]	蒋正财.结直肠癌根治术后复发转移的危险因素分析[J].中华全科医学, 2013, 11(11): 1676-1678. JIANG Zhengcai. The risk factors of recurrence and metastasis after radical resection of colorectal cancer[J]. Chinese Journal of General Prictice, 2013, 11(11):1676-1678.
[19]	Hwang K, Park IJ, Yu CS, et al. mpression of prognosis regarding pathologic stage after preoperative chemoradiotherapy in rectal cancer[J]. World J Gastroenterol, 2015, 21(2): 563-570.
[20]	Wei XL, Wang DS, Xi SY, et al. Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer[J]. World J Gastroenterol, 2014, 20(48): 18404-18412.

Full-Text